V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Director – Formulation and Drug Product Development

Bioprocess & BiomanufacturingUpdated on Nov 11
Full-timeWaltham, MA, USA

About the Job

Requirements

  • A Ph.D. in Pharmaceutical Sciences, Chemistry, Chemical Engineering, Biochemistry, Biology, or a related scientific discipline with 8 or more years of relevant industry experience is strongly preferred; alternatively, an M.S. with 10 or more years of relevant industry experience or a B.S. with 12 or more years of relevant industry experience is accepted.
  • Demonstrated experience supporting products from early clinical development through late-stage development, process validation, and commercial readiness.
  • Experience working with external contract development and manufacturing organizations (CDMOs) and managing outsourced development and manufacturing activities.
  • Deep understanding of protein formulation science, including degradation pathways, stabilization mechanisms, excipient selection, and formulation optimization.
  • Strong foundation in analytical characterization techniques and the ability to use analytical data to guide formulation and process development decisions.
  • Demonstrated expertise in experimental design, data analysis, interpretation of complex datasets, and application of scientific principles to solve technical challenges.
  • Strong written, verbal, and executive-level communication skills, with the ability to operate with significant autonomy, sound judgment, and high accountability in a fast-paced matrix environment.
  • Strong commitment to ethical standards.
  • Proficiency with Microsoft Office, including Word, PowerPoint, Excel, Outlook, and SharePoint.
  • Ability to travel up to 15%.

Responsibilities

  • Lead formulation development activities for biologic products, including formulation design, excipient selection, stability strategy development, and support of clinical and commercial dosage forms.
  • Develop scientifically sound formulation and drug product development strategies that balance product quality, manufacturability, patient needs, regulatory expectations, and program timelines.
  • Design, oversee, and interpret formulation development, process development, characterization, and validation studies using risk-based and data-driven approaches.
  • Apply understanding of protein structure, degradation pathways, formulation mechanisms, and product quality attributes to guide development decisions and address technical challenges.
  • Use analytical data and product characterization results to investigate stability trends, define formulation risks, support root-cause analyses, and enable informed decision-making.
  • Lead drug product process development activities, including fill-finish process development, scale-up, technology transfer, process characterization, and process validation.
  • Provide technical leadership for external CDMOs and manufacturing partners supporting formulation development, drug product development, technology transfer, and commercial readiness activities.
  • Review and approve technical protocols, reports, manufacturing documentation, investigations, change controls, and development plans.
  • Serve as the drug product development representative on cross-functional project teams and contribute to overall chemistry, manufacturing, and controls (CMC) strategy and program execution.
  • Author and review drug product and formulation sections of regulatory submissions, health authority responses, and other technical documents.
  • Assess technical risks, develop mitigation strategies, and drive resolution of formulation, manufacturing, and product quality challenges.
  • Maintain awareness of emerging technologies, industry trends, and regulatory expectations relevant to biologics formulation and drug product development.

Desired Qualifications

  • Experience with high-concentration protein formulations, lyophilized products, or other challenging biologic dosage forms.
  • Experience supporting combination products, including prefilled syringes and autoinjector presentations.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs